The potent inhibition of EMT in cancer produced by curcumin can also be explained by the fact that RTKs represent one of the main modes of its action, upstream of the MAPK, PI3K/Akt, JAK/STAT, and NF-κB signaling pathways (Dev et al., 2021). Here, AKT1 is linked to cancer.